Italia - italiano - myHealthbox

guna spa - serenoa repens - capsule - 40.5g - serenoa repens e vitamine - ipofertilità - integratore alimentare - spermotrend è indicato per aiutare a ridurre l’impatto negativo dello stress ossidativo sulla capacità riproduttiva maschile.

Italia - italiano - Ministero della Salute

medical pharma srl -

Unione Europea - italiano - EMA (European Medicines Agency)

roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosoppressori - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.

Unione Europea - italiano - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosoppressori - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Unione Europea - italiano - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidone - fibrosi polmonare idiopatica - immunosoppressori - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

day zero ehf - pirfenidone - pirfenidone

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

dr. reddy's s.r.l. - pirfenidone - pirfenidone

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

viatris healthcare limited - pirfenidone - pirfenidone

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

pharmathen s.a. - ropivacaina - ropivacaina

Unione Europea - italiano - EMA (European Medicines Agency)

eli lilly nederland b.v. - baricitinib - artrite, reumatoide - immunosoppressori - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant può essere usato in monoterapia o in combinazione con metotrexato. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.